A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

被引：2
|
作者：
Qian, Jiejing [1 ]
Xu, Jieyu [1 ,2 ]
Hong, Qing [1 ,2 ]
Lou, Yinjun [1 ]
Mao, Liping [1 ]
Xu, Weilai [1 ]
Yang, Min [3 ]
Yu, Wenjuan [1 ,4 ]
Meng, Haitao [1 ]
Mai, Wenyuan
Ye, Xiujing [5 ]
Zhu, Honghu [1 ]
Jin, Jie [1 ,6 ,7 ,8 ,9 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ Med, Affiliated Hosp 1, Hangzhou, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[5] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[6] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Peoples R China
[7] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China
[8] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[9] Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4414
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real world outcomes among patients with newly diagnosed acute myeloid leukemia
    Pulte, Elizabeth D.
    Fernandes, Laura L.
    Wynne, Joseph
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Bystrom, Rebecca
    Vallejo, Jonathon
    Gu, Wenjuan
    Lerro, Catherine
    Norsworthy, Kelly
    DeClaro, Angelo
    Theoret, Marc R.
    Rivera, Donna
    Wang, Ching-Kun
    CANCER RESEARCH, 2024, 84 (06)
  • [22] VENETOCLAX, AZACITIDINE, COMBINED WITH LOW-DOSE CYTARABINE IMPROVE THE REMISSION RATE IN OLDER OR UNFIT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
    Han, Xiao
    Song, Qingxiao
    Wan, Kai
    Zhang, Mengyun
    Liu, Xue
    Yan, Hongju
    Zhang, Cheng
    Wen, Qin
    Zhang, Xi
    BONE MARROW TRANSPLANTATION, 2024, 59 : 176 - 177
  • [23] Outcomes with Real-World Use of Azacitidine and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Are Comparable to Long-Term Viale-a Results
    Shah, Zalak
    Boselli, Danielle
    Begley, Stephanie
    Bose, Rupali
    Pang, Yifan
    Sanikommu, Srinivasa Reddy
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Knight, Thomas G.
    Ai, Jing
    Avalos, Belinda
    Copelan, Edward A.
    Grunwald, Michael R.
    Ragon, Brittany Knick
    BLOOD, 2024, 144 : 5194 - 5195
  • [24] Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features
    Gutman, Jonathan A.
    Winters, Amanda
    Amaya, Maria L.
    McMahon, Christine M.
    Schowinsky, Jeffrey
    Abbott, Diana
    Hammes, Andrew
    Pei, Shanshan
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD, 2020, 136
  • [25] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Leiming Xia
    Wanlu Tian
    Yiming Zhao
    Lingling Jiang
    Wei Qian
    Lei Jiang
    Ling Ge
    Jianjun Li
    Fengbo Jin
    Mingzhen Yang
    Signal Transduction and Targeted Therapy, 8
  • [26] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Xia, Leiming
    Tian, Wanlu
    Zhao, Yiming
    Jiang, Lingling
    Qian, Wei
    Jiang, Lei
    Ge, Ling
    Li, Jianjun
    Jin, Fengbo
    Yang, Mingzhen
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [27] Venetoclax Combined with Azacitidine and Homoharringtonine in Adults with Secondary Acute Myeloid Leukemia
    Huang, Fei
    Chen, Yu
    Shi, Zhongxun
    Huang, Huijun
    Li, Jianyong
    Shen, Wenyi
    BLOOD, 2023, 142
  • [28] The impact of secondary-type mutations in newly diagnosed acute myeloid leukemia treated with venetoclax and decitabine or azacitidine
    Doyel, Michael
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Thuy Ho
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
    Guinan, Kimberly
    Mathurin, Karine
    Au, Yunghan
    Schuh, Andre C.
    Bui, Cat N.
    Chai, Xinglei
    Lachaine, Jean
    CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536
  • [30] A prospective study of all-trans retinoic acid plus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia.
    Gu, Chengyuan
    Wang, Ruju
    Kang, Huizhu
    He, Xuefeng
    Chen, Jun
    Lin, Zhihong
    Liu, Yuejun
    Yang, Ting
    Wu, Depei
    Han, Yue
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345